Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool

• المؤلفون الرئيسيون: Xiao-yi Bao (مؤلف), Qun Zheng (مؤلف), Qiang Tong (مؤلف), Peng-chong Zhu (مؤلف), Zhuang Zhuang (مؤلف), Guo-qing Zheng (مؤلف), Yan Wang (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background: Danshensu (DSS) possesses unique bioactivity on the cardiovascular system. However, there is a lack of systematical summary of DSS for acute myocardial ischemia injury and no quality assessment tool for the systematical review of cell experiments. Here, we aimed to assess the preclinical...